We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$1.46B
AUM Growth
+$222M
Cap. Flow
+$49.8M
Cap. Flow %
3.4%
Top 10 Hldgs %
67.23%
Holding
266
New
5
Increased
172
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$167M
2
AMZN icon
Amazon
AMZN
+$5.51M
3
ABT icon
Abbott
ABT
+$4.26M
4
AGN
Allergan plc
AGN
+$2.31M
5
XYZ
Block Inc
XYZ
+$2.26M

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$1.73M
2
ADT
ADT Corp
ADT
+$915K
3
SDS icon
ProShares UltraShort S&P500
SDS
+$791K
4
KMI icon
Kinder Morgan
KMI
+$550K
5
MO icon
Altria Group
MO
+$425K

Sector Composition

Rank Sector Weight
1 Healthcare 58.41%
2 Energy 12.88%
3 Utilities 5.3%
4 Consumer Staples 4.25%
5 Communication Services 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRH icon
101
CRH
CRH
$63.9B
$1.68M 0.11%
56,854
+3,434
+6% +$101K
CPGX
102
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
$1.66M 0.11%
65,011
+312
+0.5% +$7.95K
AJG icon
103
Arthur J. Gallagher & Co
AJG
$65.9B
$1.65M 0.11%
34,662
+277
+0.8% +$12.8K
JCI icon
104
Johnson Controls International
JCI
$87.2B
$1.62M 0.11%
35,023
+236
+0.7% +$10.4K
IBM icon
105
IBM
IBM
$209B
$1.51M 0.1%
10,389
+85
+0.8% +$12.2K
MPLX icon
106
MPLX
MPLX
$58.5B
$1.47M 0.1%
43,719
+112
+0.3% +$3.55K
HON icon
107
Honeywell
HON
$76.7B
$1.45M 0.1%
13,894
+51
+0.4% +$5.24K
TRIP icon
108
TripAdvisor
TRIP
$1.65B
$1.44M 0.1%
22,450
– –
CVS icon
109
CVS Health
CVS
$134B
$1.44M 0.1%
15,038
+8
+0.1% +$797
ORAN
110
DELISTED
Orange
ORAN
$1.42M 0.1%
86,341
+4,100
+5% +$68.5K
UNP icon
111
Union Pacific
UNP
$172B
$1.41M 0.1%
16,201
+65
+0.4% +$5.5K
LOW icon
112
Lowe's Companies
LOW
$118B
$1.41M 0.1%
17,778
+66
+0.4% +$5.11K
WMT icon
113
Walmart Inc
WMT
$884B
$1.35M 0.09%
55,629
+306
+0.6% +$7.08K
RCI icon
114
Rogers Communications
RCI
$18.4B
$1.3M 0.09%
32,199
+196
+0.6% +$7.61K
NDAQ icon
115
Nasdaq
NDAQ
$53.2B
$1.29M 0.09%
60,009
– –
AZN icon
116
AstraZeneca
AZN
$266B
$1.27M 0.09%
21,012
+1,025
+5% +$59.5K
BT
117
DELISTED
BT Group plc (ADR)
BT
$1.25M 0.09%
44,783
+2,100
+5% +$65.9K
KEY icon
118
KeyCorp
KEY
$24.2B
$1.23M 0.08%
111,222
+719
+0.7% +$8.57K
MAS icon
119
Masco
MAS
$14.2B
$1.23M 0.08%
39,696
+119
+0.3% +$3.75K
CMCSA icon
120
Comcast
CMCSA
$84B
$1.17M 0.08%
35,786
+6
+0% +$186
RDS.B
121
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.16M 0.08%
20,789
+1,000
+5% +$51.4K
SLB icon
122
SLB Ltd
SLB
$72.6B
$1.15M 0.08%
14,574
+4
+0% +$307
CPPL
123
DELISTED
Columbia Pipeline Partners LP
CPPL
$1.15M 0.08%
76,800
– –
ALL icon
124
Allstate
ALL
$68.3B
$1.15M 0.08%
16,446
+80
+0.5% +$5.36K
PPLI
125
People Inc
PPLI
$3.08B
$1.15M 0.08%
114,118
– –
3 4
5
6 7

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return

Bollard Group's Q2 2016 Portfolio in Review

As of Q2 2016, Bollard Group held 266 positions worth $1.46B, up 18% from $1.24B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bollard Group deployed $49.8M of net new capital in Q2 2016, opening 5 new positions and adding to 172 existing holdings. Its largest new stake was Allergan plc: 10,000 shares worth $2.31M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 44% a quarter earlier, followed by Energy and Utilities.

On the sell side, the largest reduction was ProShares Short S&P500, an estimated $1.73M trimmed.

  • Bollard Group's largest Q2 2016 buy was Allergan plc: 10,000 shares worth $2.31M.
  • Bollard Group added most to Boston Scientific in Q2 2016, an estimated $167M increase.
  • Bollard Group's biggest Q2 2016 reduction was ProShares Short S&P500, cutting an estimated $1.73M.
  • Bollard Group fully exited ADT Corp in Q2 2016, selling an estimated $915K.
  • Bollard Group's ten largest holdings make up 67% of its $1.46B portfolio in Q2 2016.
  • Bollard Group opened 5 new positions and closed 8 in Q2 2016.
  • Bollard Group's portfolio value rose 18% quarter-over-quarter to $1.46B.

Based on Bollard Group's 13F filing for Q2 2016, filed 20 Jul 2016.